Biological
Yttrium Y 90 Basiliximab clinical trials
Keep track of what changes. Save the Yttrium Y 90 Basiliximab studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
3 studies that test it; most in 2013 (1)
| Year | Studies |
|---|---|
| 2013 | 1 |
| 2020 | 1 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 3
Often tested with
Tested in the same studies.
Carmustine (2) · Etoposide (2) · Cytarabine (2) · Melphalan (1) · Basiliximab (1) · Genetically Engineered Hematopoietic Stem Progenitor Cells (1) · Recombinant Granulocyte Colony-Stimulating Factor (1)
Related medicines
As reviewed, each with the page that says it.
- One of Radiopharmaceuticals source
Studies
Open first, then newest update. How each study uses Yttrium Y 90 Basiliximab is read from its arms, and is right about nine times in ten.
Testing it · 3
- Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin LymphomaRecruitingPhase 2City of Hope Medical CenterNCT04871607Written as Yttrium Y 90 Basiliximab
- Radiolabeled Monoclonal Antibody Therapy and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Primary Refractory or Relapsed Hodgkin LymphomaCompletedPhase 1City of Hope Medical CenterNCT01476839Written as yttrium Y 90-labeled basiliximab
- Yttrium Y 90 Basiliximab and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Mature T-cell Non-Hodgkin LymphomaCompletedPhase 1City of Hope Medical CenterNCT02342782Written as Yttrium Y 90 Basiliximab